Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Curve type (GR values) | Curve type (relative cell counts) | Experiment name | Number of concentrations | Cell doublings (DMSO control) | GR50 | GRmax | GR_AOC | GEC50 | GRinf | Hill slope (GR values) | R-squared sigmoid fit (GR values) | P-value sigmoid fit (GR values) | R-squared flat fit (GR values) | IC50 | Emax | AUC | EC50 | Einf | Hill slope (relative cell counts) | R-squared sigmoid fit (relative cell counts) | P-value sigmoid fit (relative cell counts) | R-squared flat fit (relative cell counts) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC38 | KIN001-244 | 2 | 72 | flat | flat | HCC38 KIN001-244 0 2 72 | 8 | 2.210 | Inf | 0.948 | 0.0304 | 0.0 | 0.948 | 0.01 | -0.0213 | 1.0 | 0.969 | Inf | 0.944 | 0.967 | 0.0 | 0.944 | 0.01 | -0.0218 | 1.0 | 0.966 |
HCC38 | KIN001-244 | 1 | 72 | sigmoid | sigmoid | HCC38 KIN001-244 0 1 72 | 8 | 1.751 | Inf | 0.894 | 0.0375 | 4.46 | 0.77 | 0.479 | 0.71 | 0.0244 | NA | Inf | 0.909 | 0.968 | 4.5 | 0.802 | 0.474 | 0.705 | 0.0256 | NA |
HCC38 | Omipalisib | 3 | 72 | sigmoid | sigmoid | HCC38 omipalisib 0 3 72 | 8 | 1.446 | 0.0145 | -0.503 | 0.802 | 0.0539 | -0.597 | 0.6 | 0.993 | 3.08e-07 | NA | 0.0449 | 0.134 | 0.499 | 0.0308 | 0.107 | 0.644 | 0.993 | 2.98e-07 | NA |
HCC38 | Omipalisib | 2 | 72 | sigmoid | sigmoid | HCC38 omipalisib 0 2 72 | 8 | 2.124 | 0.0404 | -0.47 | 0.634 | 0.45 | -1.0 | 0.456 | 0.979 | 9.71e-06 | NA | 0.0507 | 0.0595 | 0.494 | 0.0507 | 0.0 | 0.556 | 0.96 | 6.44e-05 | NA |
HCC38 | Omipalisib | 1 | 72 | sigmoid | sigmoid | HCC38 omipalisib 0 1 72 | 8 | 1.760 | 0.0231 | -0.316 | 0.672 | 0.152 | -0.638 | 0.438 | 0.97 | 2.61e-05 | NA | 0.0585 | 0.151 | 0.512 | 0.0499 | 0.0356 | 0.465 | 0.956 | 8.65e-05 | NA |
HCC38 | GDC-0980 | 3 | 72 | sigmoid | sigmoid | HCC38 apitolisib 0 3 72 | 8 | 1.437 | 0.371 | -0.0189 | 0.29 | 0.513 | -0.179 | 0.946 | 0.993 | 3.35e-07 | NA | 0.96 | 0.359 | 0.808 | 0.393 | 0.295 | 0.998 | 0.993 | 3.51e-07 | NA |
HCC38 | GDC-0980 | 2 | 72 | sigmoid | sigmoid | HCC38 apitolisib 0 2 72 | 8 | 2.159 | 0.33 | 0.153 | 0.279 | 0.253 | 0.117 | 1.0 | 0.992 | 4.91e-07 | NA | 0.385 | 0.304 | 0.749 | 0.165 | 0.308 | 1.13 | 0.994 | 2.09e-07 | NA |
HCC38 | GDC-0980 | 1 | 72 | sigmoid | sigmoid | HCC38 apitolisib 0 1 72 | 8 | 1.777 | 0.317 | 0.114 | 0.305 | 0.295 | 0.0315 | 0.91 | 0.99 | 9.47e-07 | NA | 0.623 | 0.354 | 0.761 | 0.219 | 0.315 | 0.951 | 0.989 | 1.26e-06 | NA |
HCC38 | Pictilisib | 3 | 72 | sigmoid | sigmoid | HCC38 pictilisib 0 3 72 | 8 | 1.420 | 3.12 | 0.499 | 0.129 | 2.45 | 0.0818 | 0.738 | 0.976 | 1.33e-05 | NA | 20.5 | 0.664 | 0.911 | 2.24 | 0.401 | 0.731 | 0.974 | 1.7e-05 | NA |
HCC38 | Pictilisib | 2 | 72 | sigmoid | sigmoid | HCC38 pictilisib 0 2 72 | 8 | 2.112 | Inf | 0.622 | 0.0838 | 0.644 | 0.58 | 1.32 | 0.933 | 0.000298 | NA | Inf | 0.642 | 0.918 | 0.568 | 0.612 | 1.36 | 0.922 | 0.000475 | NA |
HCC38 | Pictilisib | 1 | 72 | sigmoid | sigmoid | HCC38 pictilisib 0 1 72 | 8 | 1.759 | 7.16 | 0.562 | 0.125 | 1.04 | 0.377 | 0.725 | 0.992 | 5.12e-07 | NA | Inf | 0.647 | 0.896 | 0.797 | 0.529 | 0.742 | 0.992 | 5.77e-07 | NA |
HCC38 | Everolimus | 3 | 72 | sigmoid | sigmoid | HCC38 everolimus 0 3 72 | 8 | 1.437 | 5.11 | 0.511 | 0.429 | 0.000567 | 0.299 | 0.1 | 0.934 | 0.000284 | NA | 573000000.0 | 0.668 | 0.707 | 0.000349 | 0.53 | 0.1 | 0.932 | 0.000308 | NA |
HCC38 | Everolimus | 2 | 72 | sigmoid | flat | HCC38 everolimus 0 2 72 | 8 | 2.170 | 8323.0 | 0.58 | 0.376 | 0.000127 | 0.417 | 0.1 | 0.688 | 0.0303 | NA | Inf | 0.6 | 0.637 | 0.0 | 0.6 | 0.01 | 0.509 | 0.119 | 0.637 |
HCC38 | Everolimus | 1 | 72 | sigmoid | flat | HCC38 everolimus 0 1 72 | 8 | 1.703 | 11.8 | 0.54 | 0.428 | 0.000126 | 0.341 | 0.1 | 0.688 | 0.0303 | NA | Inf | 0.641 | 0.664 | 0.0 | 0.641 | 0.01 | 0.571 | 0.0788 | 0.665 |
HCC38 | CAL-101 | 3 | 72 | sigmoid | sigmoid | HCC38 idelalisib 0 3 72 | 8 | 1.443 | Inf | 0.851 | 0.0804 | 4.08 | 0.726 | 0.225 | 0.706 | 0.0254 | NA | Inf | 0.894 | 0.943 | 4.27 | 0.804 | 0.222 | 0.707 | 0.0252 | NA |
HCC38 | CAL-101 | 2 | 72 | sigmoid | sigmoid | HCC38 idelalisib 0 2 72 | 8 | 2.154 | Inf | 0.881 | 0.0205 | 0.901 | 0.879 | 3.37 | 0.892 | 0.00125 | NA | Inf | 0.876 | 0.979 | 0.891 | 0.874 | 3.37 | 0.887 | 0.00144 | NA |
HCC38 | CAL-101 | 1 | 72 | sigmoid | sigmoid | HCC38 idelalisib 0 1 72 | 8 | 1.723 | Inf | 0.92 | 0.00328 | 1.18 | 0.903 | 1.47 | 0.768 | 0.0125 | NA | Inf | 0.932 | 0.997 | 1.16 | 0.918 | 1.48 | 0.763 | 0.0133 | NA |
HCC38 | Alpelisib | 3 | 72 | flat | flat | HCC38 alpelisib 0 3 72 | 8 | 1.398 | Inf | 0.75 | 0.0995 | 0.0 | 0.75 | 0.01 | 0.141 | 0.634 | 0.883 | Inf | 0.829 | 0.932 | 0.0 | 0.829 | 0.01 | 0.113 | 0.698 | 0.92 |
HCC38 | Alpelisib | 2 | 72 | flat | flat | HCC38 alpelisib 0 2 72 | 8 | 2.086 | Inf | 0.848 | 0.0559 | 0.0 | 0.848 | 0.01 | -0.0371 | 1.0 | 0.931 | Inf | 0.848 | 0.944 | 0.0 | 0.848 | 0.01 | -0.0359 | 1.0 | 0.932 |
HCC38 | Alpelisib | 1 | 72 | flat | flat | HCC38 alpelisib 0 1 72 | 8 | 1.738 | Inf | 0.757 | 0.0835 | 0.0 | 0.757 | 0.01 | 0.593 | 0.0674 | 0.909 | Inf | 0.798 | 0.929 | 0.0 | 0.798 | 0.01 | 0.579 | 0.0744 | 0.923 |
HCC38 | BX-912 | 3 | 72 | sigmoid | sigmoid | HCC38 BX-912 0 3 72 | 8 | 1.454 | 0.422 | -0.428 | 0.365 | 0.478 | -0.433 | 5.0 | 0.993 | 4.02e-07 | NA | 0.496 | 0.162 | 0.778 | 0.46 | 0.159 | 5.0 | 0.989 | 1.24e-06 | NA |
HCC38 | BX-912 | 2 | 72 | sigmoid | sigmoid | HCC38 BX-912 0 2 72 | 8 | 2.186 | 0.583 | -0.229 | 0.251 | 0.648 | -0.233 | 3.62 | 0.999 | 9.58e-10 | NA | 0.602 | 0.124 | 0.807 | 0.559 | 0.123 | 3.78 | 0.998 | 1.03e-08 | NA |
HCC38 | BX-912 | 1 | 72 | sigmoid | sigmoid | HCC38 BX-912 0 1 72 | 8 | 1.760 | 0.529 | -0.322 | 0.274 | 0.591 | -0.322 | 4.49 | 0.999 | 1.36e-10 | NA | 0.584 | 0.149 | 0.818 | 0.541 | 0.149 | 4.63 | 0.999 | 8.39e-10 | NA |
HCC38 | Buparlisib | 3 | 72 | sigmoid | sigmoid | HCC38 buparlisib 0 3 72 | 8 | 1.431 | 0.674 | -0.377 | 0.272 | 1.67 | -1.0 | 1.21 | 0.991 | 6.94e-07 | NA | 1.11 | 0.188 | 0.824 | 1.11 | 0.0 | 1.32 | 0.987 | 2.46e-06 | NA |
HCC38 | Buparlisib | 2 | 72 | sigmoid | sigmoid | HCC38 buparlisib 0 2 72 | 8 | 2.142 | 0.876 | -0.185 | 0.172 | 1.24 | -0.413 | 1.74 | 0.996 | 5.03e-08 | NA | 0.959 | 0.146 | 0.861 | 0.893 | 0.0606 | 1.8 | 0.992 | 4.3e-07 | NA |